Bowel perforation associated with intraperitoneal chromic phosphate instillation.
Intraperitoneal chromic phosphate is widely used as adjuvant therapy in the treatment of early-stage ovarian epithelial carcinoma. Delayed bowel injury is an infrequently observed complication of chromic phosphate administration. This report presents a case of colon perforation which occurred 4 months after treatment with intraperitoneal chromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.